Epibiotech
Latest round
- Series B
Last raised
- Mar 2021
Total raised
- $12M
Investors
- 5
About Epibiotech
Epi Biotech, based in South Korea, focuses on developing innovative biopharmaceuticals to treat hair loss by utilizing advanced cellular and genetic therapies., Ltd. was founded in 2015 in Incheon, South Korea. The company specializes in developing biopharmaceuticals for hair loss treatment., Ltd. was founded in 2015 in Incheon, South Korea. The company specializes in developing biopharmaceuticals for hair loss treatment.36 billion post-money. Epi Biotech specializes in the development of advanced biopharmaceuticals aimed at addressing unmet medical needs in hair loss treatment. The company's core product offerings include cellular, genetic, and antibody-based therapies designed to stimulate hair regrowth and improve hair follicle health. These products are part of a comprehensive solution targeting various forms of alopecia, leveraging technologies such as stem cell and gene therapy. Epi Biotech serves a diverse client base including research institutions, biotech firms, and healthcare providers, particularly in Asian markets like South Korea and China, and has engaged in collaborative research initiatives, such as a recent symposium with Yonsei University's Comprehensive Pharmaceutical Research Institute. Epi Biotech's revenue model is structured around collaborations and partnerships with research institutions and healthcare organizations, facilitating the distribution of its biopharmaceutical products. The company engages in business-to-business (B2B) transactions, providing its therapies directly to academic and medical entities. Revenue generation is supported through contractual agreements for research, development, and clinical trials of proprietary products, with pricing structures tailored to client needs, ensuring competitive positioning in the biotech sector. Epi Biotech plans to launch new products aimed at enhancing hair loss treatment, with specific release dates yet to be announced. The company is targeting expansion into the Chinese market by 2024 to broaden its geographic reach. Additionally, in July 2023, Epi Biotech was listed on the KONEX stock exchange, marking a significant milestone for the company.
Who invested in Epibiotech
5 investors across 2 rounds
See all investors in Epibiotech
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Epibiotech
Who invested in Epibiotech?
Epibiotech has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Epibiotech raised?
Epibiotech has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Epibiotech last raise money?
Epibiotech's most recent round on record is a Series B, in Mar 2021.
What does Epibiotech do?
Epi Biotech, based in South Korea, focuses on developing innovative biopharmaceuticals to treat hair loss by utilizing advanced cellular and genetic therapies.
Where is Epibiotech headquartered?
Epibiotech is headquartered in Incheon, South Korea.
Which VCs invest in companies like Epibiotech?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Epibiotech's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Epibiotech? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.